Home > Insider Trading > Filing (0001567619-21-002591)

Filing Details

Accession Number:: 0001567619-21-002591
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-09 15:08:19
Reporting Period:: 2021-02-09

Accepted Time:: 2021-02-09 15:08:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831363	Terns Pharmaceuticals Inc.	TERN	()	1231

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1618788	Vivo Capital Fund Viii, L.p.	C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301	No	No	Yes	No
1618789	Vivo Capital Viii, Llc	C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301	No	No	Yes	No
1628048	Vivo Capital Surplus Fund Viii, L.p.	C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301	No	No	Yes	No
1726403	Vivo Opportunity Fund, L.p.	C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301	No	No	Yes	No
1728970	Vivo Opportunity, Llc	C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-09	1,933,185	$0.00	1,933,185	No	4	C	Indirect	Vivo Capital Fund VIII, L.P.
Common Stock	Acquisiton	2021-02-09	266,948	$0.00	266,948	No	4	C	Indirect	Vivo Capital Surplus Fund VIII, L.P.
Common Stock	Acquisiton	2021-02-09	103,372	$17.00	2,036,557	No	4	P	Indirect	Vivo Capital Fund VIII, L.P.
Common Stock	Acquisiton	2021-02-09	14,275	$17.00	281,223	No	4	P	Indirect	Vivo Capital Surplus Fund VIII, L.P.
Common Stock	Acquisiton	2021-02-09	357,353	$17.00	357,353	No	4	P	Indirect	Vivo Opportunity Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Vivo Capital Fund VIII, L.P.
No	4	C	Indirect	Vivo Capital Surplus Fund VIII, L.P.
No	4	P	Indirect	Vivo Capital Fund VIII, L.P.
No	4	P	Indirect	Vivo Capital Surplus Fund VIII, L.P.
No	4	P	Indirect	Vivo Opportunity Fund, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	713,203	$0.00	1,569,047	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-02-09	98,484	$0.00	216,666	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-02-09	364,138	$0.00	364,138	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-02-09	50,282	$0.00	50,282	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series B Preferred Stock automatically converted on a 1-for-2.2 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of each of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P., the record holder of the securities. Dr. Hongbo Lu is a Managing Partner at Vivo Capital LLC and a member of the Issuer's board of directors. Frank Kung, Edgar Engleman and Shan Fu are managing members of Vivo LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Each share of Series C Preferred Stock automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund, L.P. Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang are managing members of Vivo Opportunity, LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.